HAEAMBIO CO.,LTD.

HAEAMBIO Co., Ltd. is we are at the forefront of cutting-edge medical research and technology development with the aim of contributing to a healthier future for humanity. As the era of super-aging approaches, the prevalence of cardiovascular diseases is rapidly increasing. Our goal is to develop new drugs and provide therapeutic solutions for major unresolved conditions, such as aortic valve stenosis, heart failure with preserved ejection fraction, and post-myocardial infarction heart failure.

We leverage our network with leading hospitals and research institutions both domestically and internationally to identify new targets for heart disease treatment. Based on this foundation, we have secured core technologies including patient-derived valve cell isolation, gene profiling, and the discovery and validation of calcification-related genes. Additionally, we focus on elucidating the efficacy of therapeutics using various animal models and studying mechanisms at the genetic, molecular, and cellular levels. Our research aims to develop concrete treatment methods that can be applied in real-world medical settings.

HAEAMBIO Co., Ltd. is relentlessly challenging itself to develop technologies that enable the fundamental treatment of diseases, creating a future where healthy living is possible for everyone, everywhere in the world. We invite you to join us in exploring new possibilities and embarking on a journey towards a healthier tomorrow.